FF announces $41 million strategic investment in Nasdaq-listed company QLGN
On September 20, 2025, Beijing time, Faraday Future Intelligent Electric Inc. (FF) and Qualigen Therapeutics, Inc. (NASDAQ: QLGN, "QLGN") jointly announced that they have signed a securities purchase agreement. FF will invest in QLGN's common and preferred shares through a private placement (PIPE) and will fully collaborate on crypto and Web3 initiatives. The PIPE investment, totaling approximately US$41 million, was led by Faraday Future and its founder and co-CEO, Jia Yueting. Other investors include SIGN Foundation, a blockchain technology company backed by Binance Labs, Sequoia Capital (US, India, and China), IDG, and Circle. FF Global President Jerry Wang also participated in this round.